A number of firms have modified their ratings and price targets on shares of DENTSPLY SIRONA (NASDAQ: XRAY) recently:
- 10/30/2026 – DENTSPLY SIRONA had its “sell (e+)” rating reaffirmed by Weiss Ratings.
- 10/26/2026 – DENTSPLY SIRONA had its price target lowered by Barrington Research from $15.00 to $13.00. They now have an “outperform” rating on the stock.
- 10/22/2026 – DENTSPLY SIRONA had its price target lowered by Mizuho from $14.00 to $12.00. They now have a “neutral” rating on the stock.
- 10/14/2026 – DENTSPLY SIRONA had its price target lowered by Leerink Partners from $14.00 to $10.00. They now have a “market perform” rating on the stock.
- 10/9/2026 – DENTSPLY SIRONA had its price target lowered by Piper Sandler from $14.00 to $12.00. They now have a “neutral” rating on the stock.
- 9/17/2026 – DENTSPLY SIRONA had its price target lowered by BMO Capital Markets from $13.00 to $10.00. They now have a “market perform” rating on the stock.
DENTSPLY SIRONA Stock Performance
Shares of NASDAQ:XRAY traded up $0.92 during midday trading on Wednesday, reaching $10.65. The company had a trading volume of 6,672,912 shares, compared to its average volume of 4,896,255. The stock has a market cap of $2.12 billion, a P/E ratio of -3.87, a P/E/G ratio of 1.27 and a beta of 0.87. The company’s 50 day moving average price is $9.66 and its 200 day moving average price is $11.31. The company has a current ratio of 1.63, a quick ratio of 1.07 and a debt-to-equity ratio of 1.48. DENTSPLY SIRONA Inc. has a 52-week low of $8.32 and a 52-week high of $14.76.
DENTSPLY SIRONA (NASDAQ:XRAY – Get Free Report) last released its earnings results on Thursday, August 6th. The medical instruments supplier reported $0.52 earnings per share for the quarter, beating analysts’ consensus estimates of $0.35 by $0.17. DENTSPLY SIRONA had a negative net margin of 14.99% and a positive return on equity of 20.84%. The firm had revenue of $898.00 million for the quarter, compared to analysts’ expectations of $889.93 million. During the same period in the previous year, the company earned $0.52 earnings per share. The company’s quarterly revenue was down 4.1% on a year-over-year basis. DENTSPLY SIRONA has set its FY 2026 guidance at 1.400-1.500 EPS. As a group, sell-side analysts anticipate that DENTSPLY SIRONA Inc. will post 1.39 EPS for the current fiscal year.
DENTSPLY SIRONA is a global manufacturer of professional dental products and technologies. The company serves dentists, dental specialists, dental laboratories and other oral health professionals with solutions used in preventive, restorative, prosthetic, endodontic and implant dentistry.
Its portfolio includes dental equipment, imaging and treatment systems, CAD/CAM technology, consumable dental materials, orthodontic products, endodontic instruments and solutions, dental implants, prosthetic components and laboratory products.
Read More
- Five stocks we like better than DENTSPLY SIRONA
- Why ExxonMobil and Chevron Reminded Investors to Keep it Simple
- Amazon Has Erased Its Earnings Sell-Off, But Is the Biggest Opportunity Still Ahead?
- onsemi’s AI Sales Surge 175%: Is a Stock Recovery Next?
- Energy Transfer’s Earnings Miss May Be Hiding Its Strongest Advantage
Receive News & Ratings for DENTSPLY SIRONA Inc Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for DENTSPLY SIRONA Inc and related companies with MarketBeat.com's FREE daily email newsletter.
